Concepedia

Oliver Pohl

OP

Statistics

Publications

16

Citations

508

H-Index

14

Active since

2007

Affiliations

ObsEva (Switzerland)(Current)

Imperial College London

PregLem (Switzerland)

St George's, University of London

Hammersmith Hospital

Oliver Pohl is an author at ObsEva (Switzerland) specializing in pharmacology, medicine, and clinical pharmacology.

Publications per year

2007–2023

16

Publications

16

Ginkgo Biloba Extract (EGb 761) Independently Improves Changes in Passive Avoidance Learning and Brain Membrane Fluidity in the Aging Mouse

S. Stoll, K. Scheuer, Oliver Pohl et al. · Pharmacopsychiatry · 2007 · 128 citations

, , +16

The mechanism of action of oxytocin antagonist nolasiban in ART in healthy female volunteers

Piotr Pierzyński, Oliver Pohl, Line Marchand et al. · Reproductive BioMedicine Online · 2021 · 55 citations

, , +4

Oxytocin Receptor Antagonists, Atosiban and Nolasiban, Inhibit Prostaglandin F2α-induced Contractions and Inflammatory Responses in Human Myometrium

Sung Hye Kim, Lucia Riaposova, Hauwa Ahmed et al. · Scientific Reports · 2019 · 46 citations · Full text

, , +17

Ulipristal acetate - safety and pharmacokinetics following multiple doses of 10-50 mg per day

Oliver Pohl, I. Osterloh, Jean‐Pierre Gotteland · Journal of Clinical Pharmacy and Therapeutics · 2013 · 37 citations

, , +15

OBE022, an Oral and Selective Prostaglandin F2 Receptor Antagonist as an Effective and Safe Modality for the Treatment of Preterm Labor

Oliver Pohl, André Chollet, Sung Hye Kim et al. · Journal of Pharmacology and Experimental Therapeutics · 2018 · 31 citations · Full text

, , +16

1–5 of 16